期刊文献+

吸入用复方异丙托溴铵溶液联合雾化吸入治疗慢性阻塞性肺疾病效果探讨 被引量:2

Effect of Combined Inhalation of Compound Ammonium Bromide Solution in the Treatment of Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的探究复方异丙托溴铵溶液联合雾化吸入治疗慢性阻塞性肺疾病的临床效果。方法随机分为对照组和观察组,每组59例,对照组采取常规治疗,观察组在对照组的基础上进行复方异丙托溴铵溶液联合雾化吸入治疗。结果观察组的总有效率为83.1%,对照组的总有效率为45.8%,两组相比差异具有统计学意义(P<0.05)。治疗后观察组的血氧饱和度的改善情况与对照组相比差异均具有统计学意义(P<0.05)。结论复方异丙托溴铵溶液联合雾化吸入治疗慢性阻塞性肺疾病具有显著的治疗效果,能缩短患者的住院时间。 Objective To explore the clinical effect of combined treatment of chronic obstructive puhnonary disease with the treatment of compound ammonium bromide solution combined with atomization inhalation in the treatment of chronic obstructive pulmonary disease. Methods Randomly divided into control group and observation group, 59 cases in each group, control group treated with conventional, on the basis of the observation group in the control group compound isopropyl bromide solution joint atomization inhalation therapy. Results Observation group total effective rate was 83.1%, control group total effective rate was 45.8%, compared two groups statistically significant difference (P〈0.05). Treatment group of blood oxygen saturation was observed after the differences were statistically significant compared with control subjects (P〈0.05). Conclusion The trcatmcnt of chronic obstructive pulmonary disease with the combined treatment of compound ammonium bromide solution and atomization inhalation can shorten the length of hospital stay.
作者 杨建华
出处 《中国继续医学教育》 2015年第22期133-134,共2页 China Continuing Medical Education
关键词 复方异丙托溴铵溶液 雾化吸入 慢性阻塞性肺疾病 Compound ammonium bromide solution, Atomization inhalation, Chronic obstructive pulmonary disease
  • 相关文献

二级参考文献28

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 3Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease(Revised 2011 ) . GOLD Executive Committee 2011. 被引量:1
  • 4Fromer L, Barnes T, Garvey C, et al. Innovations to achieve excellence in COPD diagnosis and treatment in primary care. Postgrad Med ,2010,122 : 150-164. 被引量:1
  • 5Singh D, Brooks J, Hangau G, et al. Superiority of " triple with salmeterol/fluticasone propionate and tiotropium versus individual components in moderate to severe COPD 2008,63:592-598. therapy bromide. 被引量:1
  • 6Pasqua F,Biscione G,Crigna G,et al. Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study. Respir Med ,2010,104:412-417. 被引量:1
  • 7Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med, 2008,359: 1543-1554. 被引量:1
  • 8Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci, 2007, 80:2270-2273. 被引量:1
  • 9Saito Y, Azuma A, Morimoto T, et al. Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to macrolide therapy. Intern Med, 2008, 47:585-591. 被引量:1
  • 10Profita M, Bonanno A, Siena L, et al. Acetylcholine mediates the release of IL-8 in human bronchial epithelial ceils by a NFkB/ERK- dependent mechanism. Eur J Pharmacol, 2008,582 : 145-153. 被引量:1

共引文献8282

同被引文献14

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部